MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-03-2025
Exact Sciences Corporation Market Cap 2011-2025 | EXAS
As of December 26, 2025 Exact Sciences Corporation has a market cap of $ 18.8 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Exact Sciences Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.32 B | 11.3 B | 10.9 B | 13.1 B | 20.7 B | 12.3 B | 10.7 B | 5.73 B | 1.85 B | 605 M | 2.18 B | 902 M | 644 M | 478 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.7 B | 478 M | 7.19 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Diagnostics research industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
75.1 M | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
221 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
34.9 M | $ 0.23 | -4.78 % | $ 6.75 M |  USA |
 |
Castle Biosciences
CSTL
|
709 M | $ 39.57 | -1.31 % | $ 1.1 B | USA |
 |
DarioHealth Corp.
DRIO
|
43.4 M | $ 10.32 | 2.79 % | $ 293 M |  Israel |
 |
DexCom
DXCM
|
48.8 B | $ 67.44 | 0.03 % | $ 26 B | USA |
 |
Brainsway Ltd.
BWAY
|
240 M | $ 19.37 | 0.41 % | $ 99.4 M | Israel |
 |
Burning Rock Biotech Limited
BNR
|
2.95 B | $ 20.47 | -3.49 % | $ 221 M |  China |
 |
Accelerate Diagnostics
AXDX
|
40.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
5.93 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
12.6 M | - | 0.22 % | $ 16.8 M | USA |
 |
BioNano Genomics
BNGO
|
3.55 M | $ 1.52 | -0.33 % | $ 1.93 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
421 M | - | - | $ 562 M |  Britain |
 |
Danaher Corporation
DHR
|
152 B | $ 229.62 | -0.66 % | $ 168 B | USA |
 |
Enzo Biochem
ENZ
|
57.5 K | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
467 M | $ 26.68 | -1.22 % | $ 807 M | USA |
 |
Global Cord Blood Corporation
CO
|
243 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
481 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
1.54 B | - | 0.12 % | $ 80.1 M | China |
 |
Myriad Genetics
MYGN
|
973 M | $ 6.43 | -1.83 % | $ 583 M | USA |
 |
ENDRA Life Sciences
NDRA
|
2.2 M | $ 5.0 | -1.96 % | $ 2.68 M | USA |
 |
Neogen Corporation
NEOG
|
1.02 B | $ 7.08 | -0.84 % | $ 1.54 B | USA |
 |
DermTech
DMTK
|
42.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
7.87 B | - | - | $ 10.7 B | USA |
 |
National Research Corporation
NRC
|
1.01 B | $ 18.5 | -0.8 % | $ 454 M | USA |
 |
CareDx, Inc
CDNA
|
521 M | $ 19.4 | -1.67 % | $ 1.04 B | USA |
 |
Celcuity
CELC
|
399 M | $ 101.97 | -0.62 % | $ 4.02 B | USA |
 |
Pacific Biosciences of California
PACB
|
1.41 B | $ 1.79 | -4.79 % | $ 454 M | USA |
 |
Anixa Biosciences
ANIX
|
70.8 K | $ 3.2 | -6.43 % | $ 102 K | USA |
 |
Koninklijke Philips N.V.
PHG
|
30.8 B | $ 26.99 | - | $ 20 B |  Niderland |
 |
Heska Corporation
HSKA
|
844 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
2.99 M | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
35.7 B | $ 225.88 | -0.03 % | $ 41 B | USA |
 |
Precipio
PRPO
|
8.7 M | $ 23.76 | -0.51 % | $ 30.8 M | USA |
 |
Quidel Corporation
QDEL
|
10.6 B | $ 28.59 | -1.11 % | $ 1.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
8.52 B | $ 45.32 | -0.35 % | $ 10.1 B | Niderland |
 |
Guardant Health
GH
|
5.84 B | $ 103.47 | 1.06 % | $ 12.7 B | USA |
 |
Aspira Women's Health
AWH
|
45.4 M | - | -6.19 % | $ 10.5 M | USA |
 |
Sotera Health Company
SHC
|
3.48 B | $ 17.68 | -0.14 % | $ 5 B | USA |
 |
Illumina
ILMN
|
16.4 B | $ 134.81 | -0.38 % | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
8.54 B | $ 202.73 | -0.57 % | $ 10.4 B | USA |
 |
Trinity Biotech plc
TRIB
|
120 M | $ 1.04 | 2.21 % | $ 61.9 M |  Irlanda |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 B | $ 175.87 | -0.01 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
92.1 M | $ 6.65 | -2.49 % | $ 862 M | USA |
 |
Motus GI Holdings
MOTS
|
990 K | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
21.1 B | $ 253.4 | -0.35 % | $ 21.3 B | USA |
 |
ICON Public Limited Company
ICLR
|
16.6 B | $ 181.86 | -0.99 % | $ 15 B | Irlanda |
 |
IDEXX Laboratories
IDXX
|
37.7 B | $ 687.75 | -0.06 % | $ 56.7 B | USA |